| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 830,942 | 895,709 | 820,489 | 951,478 | | Cost of Revenue | 133,633 | 138,273 | 138,089 | 197,107 | | | Gross Profit |
-
| 757,436 | 682,400 | 754,371 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 403,093 | 408,816 | 339,363 | 396,415 | | Non Recurring |
-
|
-
|
-
| 1,535,144 | | Others | 584,590 | 624,835 | 483,718 | 856,804 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (276,215) | (140,681) | (2,033,992) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (290,374) | (276,215) | (140,681) | (2,033,992) | | Interest Expense | 80,753 | 98,411 | 103,948 | 126,279 | | Income Before Tax | (371,127) | (374,626) | (244,629) | (2,160,271) | | Income Tax Expense | (148,170) | (166,143) | (152,982) | (281,253) | | Minority Interest | (1,193) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (224,150) | (208,483) | (91,647) | (1,879,018) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (224,150) | (208,483) | (91,647) | (1,879,018) | | Preferred Stock And Other Adjustments | (24,277) | (25,485) | (25,278) | (12,737) | | | Net Income Applicable To Common Shares | ($248,427) | ($233,968) | ($116,925) | ($1,891,755) |
|
0.31% Nasdaq 
0.05%
Income Statement
